Related Experiment Video
Updated: Jan 2, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic Testing in Inherited Heart Diseases
Jodie Ingles1, Ivan Macciocca2, Ana Morales3
1Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Insights
Genetic testing is crucial for diagnosing inherited heart conditions like hypertrophic cardiomyopathy and long QT syndrome. It helps identify at-risk family members, guiding personalized cardiovascular care.
Area of Science:
- Cardiology
- Genetics
- Clinical Medicine
Background:
- Inherited heart diseases encompass a spectrum of conditions, including hypertrophic cardiomyopathy (HCM), familial hypercholesterolaemia (FH), and inherited arrhythmia syndromes like long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS).
- Genetic testing has become a cornerstone in the clinical management of these cardiovascular disorders.
- Cardiac manifestations can be indicative of broader genetic syndromes, where genetic testing aids in etiological clarification.
Purpose of the Study:
- To highlight the evolving role and utility of genetic testing in the diagnosis and management of inherited heart diseases.
- To emphasize the importance of genetic testing in identifying at-risk asymptomatic family members.
- To underscore the need for specialized multidisciplinary clinics and genetic counseling for cardiac genetic testing.
Main Methods:
- Review of current advancements in genetic testing technologies for cardiovascular diseases.
- Analysis of the clinical utility of genetic diagnoses in inherited heart conditions.
- Discussion of the integration of genetic testing into specialized cardiac clinics.
Main Results:
- Genetic testing is now a mainstream component in managing inherited heart diseases.
- Genetic diagnoses are particularly valuable for assessing risk in asymptomatic relatives.
- Clarification of underlying causes for cardiac manifestations within wider syndromes is facilitated by genetic testing.
Conclusions:
- Genetic testing plays a pivotal role in the diagnosis and risk stratification of inherited heart diseases.
- Specialized multidisciplinary cardiac clinics with genetic counseling are essential for optimal patient care.
- Early genetic diagnosis enables proactive management and familial screening for cardiovascular genetic disorders.
Abstract:
Inherited heart diseases include numerous conditions, from the more prevalent hypertrophic cardiomyopathy (HCM) and familial hypercholesterolaemia (FH), to the comparatively less common inherited arrhythmia syndromes, such as long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT) and Brugada syndrome (BrS). Genetic testing has evolved rapidly over the last decade and is now considered a mainstream component of clinical management of inherited heart diseases. Cardiac manifestations can also be part of wider syndromes, and genetic testing can play a critical role in clarifying the underlying aetiological basis of disease in some cases. The greatest utility of a genetic diagnosis, however, comes from the ability to elucidate disease risk amongst asymptomatic at-risk family members. Given the nuances and challenges, cardiac genetic testing is best performed in a multidisciplinary specialised clinic with access to cardiac genetic counselling.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pedigree Analysis
Genetic Lingo
Dysrhythmias V: Evaluating Dysrhythmias
Animal Mitochondrial Genetics
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

